The Momnibus Act is a comprehensive legislative bill designed to improve maternal health outcomes across the United States by addressing social determinants of health, expanding access to care, and reducing disparities among pregnant and postpartum individuals. The bill establishes a federal task force to coordinate efforts between agencies and stakeholders to eliminate preventable maternal mortality and severe morbidity, while providing sustained funding to community-based organizations to address nonclinical factors like housing, nutrition, and transportation. Key provisions include extending WIC eligibility to 24 months postpartum, creating grants to grow and diversify the perinatal workforce, implementing respectful maternity care training for all healthcare employees, and establishing compliance programs to track and address bias in maternity care settings. The legislation also includes specific measures for incarcerated mothers, veterans, and vulnerable populations affected by climate change, alongside funding for maternal mental health services and technology-enabled care models to expand access in underserved areas.
This resolution designates the week of April 13 through April 19, 2026, as "National Osteopathic Medicine Week." It also recognizes the contributions of osteopathic physicians to the U.S. healthcare system and celebrates the role of osteopathic medical colleges in training future physicians.
This House Resolution supports designating the week of April 11 through April 17, 2026, as "Black Maternal Health Week." The resolution aims to bring national attention to the maternal and reproductive health crisis in the United States, specifically highlighting the importance of reducing maternal mortality and morbidity among Black women and birthing people.
This bill amends the Title X family planning program to prohibit the use of federal funds for entities that perform or financially support abortions. It allows exceptions for cases involving rape, incest, or life-threatening medical conditions, while also permitting hospitals to receive funding as long as they do not give those funds to non-hospital abortion providers. To enforce these rules, the bill requires the Secretary of Health and Human Services to submit annual reports detailing which organizations receive grants and the specific number of abortions performed under the medical and criminal exceptions.
The Breast Cancer Stamp Reauthorization Act extends the sale of a special postage stamp dedicated to breast cancer research until the year 2037. This change directly affects the United States Postal Service and the public by allowing the continued availability of this specific stamp for purchase. The bill achieves this by amending federal law to update the expiration date for the stamp's authorized sale period. No other policy changes or funding mechanisms are introduced by this legislation.
The Stop Climate Shakedowns Act of 2026 prohibits state and local governments from suing energy companies for damages related to climate change or greenhouse gas emissions. This bill declares that regulating emissions is exclusively a federal responsibility and voids any state laws that hold energy businesses liable for alleged climate harms. Consequently, all pending lawsuits of this nature against energy producers must be dismissed immediately, preventing states from imposing retroactive penalties for past lawful operations. The legislation directly affects companies involved in the production, refinement, and sale of oil, gas, and coal by shielding them from civil liability in both state and federal courts.
The Supporting VA Families Act grants unpaid parental leave to Department of Veterans Affairs employees. This provision allows employees to take four weeks of unpaid leave within a 12-month period for the birth of a child or for adoption and foster care placements. The leave is designed to supplement existing leave policies rather than replace them, ensuring employees can balance family needs with their work responsibilities. The act defines eligible employees and children according to existing federal definitions found in Title 5 of the United States Code.
The Combating Illicit Xylazine Act places xylazine - a veterinary sedative increasingly found in illicit drug mixtures - into Schedule III of the Controlled Substances Act, subjecting it to federal regulation as a controlled substance. It specifically allows veterinary use without requiring registration of the ultimate user (e.g., pet owners or veterinarians) if xylazine is dispensed by a registered veterinarian or pharmacy with a vet prescription and used for animals owned by the user, under their care, or in authorized animal programs. The bill provides a one-year delay for labeling and packaging requirements and a 60-day delay for registration and recordkeeping for veterinary use to ease implementation. Additionally, it adds xylazine to the Arcos tracking system for controlled substances and mandates two congressional reports on illicit use prevalence within 18 months and 4 years of enactment.
The ALERT Act (HR 7613) requires the Federal Aviation Administration to improve aviation safety through several key measures. It mandates the evaluation and potential implementation of enhanced collision avoidance systems (ACAS-Xa) for commercial aircraft and ACAS-Xr for rotorcraft, with specific deadlines for rulemaking and installation. The bill establishes committees to develop recommendations for safety technology requirements, requires safety risk assessments for air traffic controllers, and addresses operational procedures at high-traffic airports like Ronald Reagan Washington National. These provisions affect air carriers, air traffic controllers, rotorcraft operators, and Department of Defense aircraft operations. The act aims to enhance situational awareness and reduce midair collision risks through technology upgrades and improved safety protocols.
This bill establishes a 17-member Commission on Presidential Capacity to Discharge the Powers and Duties of the Office. This commission, composed primarily of medical professionals and former high-ranking executive officials, would be activated by a concurrent resolution of Congress. Its duty would be to conduct a medical examination of the President to determine if they are mentally or physically unable to discharge the powers and duties of the office due to conditions such as illness, disability, or substance use. Following the examination, the commission would report its findings and a declaration on the President's capacity to Congress and the Vice President, with any refusal by the President to undergo examination taken into consideration.
The HBCU Research Capacity Act establishes a Federal Clearinghouse within the Department of Education, in coordination with several other federal agencies, to provide Historically Black Colleges and Universities (HBCUs) with comprehensive information on federal grant opportunities. This Clearinghouse will identify grants supporting research and development and institutional capacity building at HBCUs, while also sharing best practices for securing federal funding. The Department of Education will notify HBCUs and Congress about the Clearinghouse and offer quarterly updates to participating institutions. Additionally, several federal agencies, including Defense, Energy, and the National Science Foundation, are mandated to review their grant programs to align with the Clearinghouse's recommendations and report any identified funding gaps to Congress annually.
The National Quantum Initiative Reauthorization Act of 2026 reauthorizes and expands federal efforts to advance quantum information science, engineering, and technology through 2034. The bill establishes new workforce development programs, including quantum education initiatives, traineeships, and a Quantum Reskilling, Education, and Workforce Coordination Hub to address talent needs. It creates an International Quantum Cooperation Strategy to foster partnerships with allies and addresses quantum supply chain vulnerabilities through mapping and planning efforts. The act includes specific funding allocations for quantum research centers, testbeds, and post-quantum cryptography development, with annual evaluations required to assess program effectiveness. The legislation directly affects federal agencies, research institutions, and the quantum industry by providing structured funding and coordination for quantum technology advancement.
